Translational Cancer Research

Translational Cancer Research

转化癌症研究

  • 4区 中科院分区
  • Q4 JCR分区

期刊简介

《Translational Cancer Research》是由AME Publishing Company出版社于2012年创办的英文国际期刊(ISSN: 2218-676X,E-ISSN: 2219-6803),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCIE收录期刊(JCR分区 Q4,中科院 4区),本刊采用OA未开放获取模式(OA占比0.6749...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比87.36%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在261篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Translational Cancer Research审稿周期约为 。该刊近年未被列入国际预警名单,年发文量约261篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 261 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q4 259 / 322

19.7%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q4 287 / 322

11.02%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:2.1 SJR:0.422 SNIP:0.39
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q3 209 / 333

37%

大类:Medicine 小类:Oncology Q3 271 / 404

33%

大类:Medicine 小类:Cancer Research Q4 183 / 230

20%

期刊发文

  • Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer

    Author: Zheng, Mengmeng; Wu, Linfeng; Xiao, Rongyao; Zhou, Yuying; Cai, Jiaohao; Chen, Weike; Chen, Chao; Sun, Kaiting; Shen, Shurong

    Journal: TRANSLATIONAL CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tcr-23-313

  • Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia

    Author: Zhang, Tong; Liao, Danying; Hu, Yu

    Journal: TRANSLATIONAL CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tcr-22-2526

  • Surgical resection of primary tumors improves survival in patients with lung metastases: a population-based SEER analysis

    Author: Liu, Tianyu; Lv, Xiaolong; Yang, Lei; Yang, Zelin; Jia, Chenhao; Chen, Huanwen

    Journal: TRANSLATIONAL CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tcr-22-2459

  • Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study

    Author: Song, Ying; Wang, Jinlu; Wang, Xiuli; Li, Rui; Niu, Xingjian; Yang, Yue; Yang, Xudong; Yin, Lei; Wang, Yiran; Zhang, Han; Shui, Ruixue; Zhang, Cuiying; An, Jing

    Journal: TRANSLATIONAL CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tcr-23-301

  • Identifying the risk factors and developing a predictive model for postoperative pelvic floor dysfunction in cervical cancer patients

    Author: Liu, Yuan-Yuan; Zhu, Wen-Hui; Li, Wei; Hao, Xia; Zheng, Wei; Shen, Qiong

    Journal: TRANSLATIONAL CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tcr-23-385

  • miR-135a inhibits the proliferation of HBV-infected hepatocellular carcinoma cells by targeting HOXA10

    Author: Lin, Jianjun; Lian, Xiang; Xue, Shihang; Ouyang, Lian; Zhou, Lihui; Lu, Yuyang; Xie, Longteng

    Journal: TRANSLATIONAL CANCER RESEARCH. 2023; Vol. 12, Issue 1, pp. 135-149. DOI: 10.21037/tcr-22-2789

  • BTN2A1-BRAF fusion may be a novel mechanism of resistance to osimertinib in lung adenocarcinoma: a case report

    Author: Kong, Wei-Min; Guo, Yong-Jun; Ma, Jie; Shi, Chao

    Journal: TRANSLATIONAL CANCER RESEARCH. 2023; Vol. 12, Issue 1, pp. 186-193. DOI: 10.21037/tcr-22-2060

  • Acute aortic dissection caused by fruquintinib for metastatic colorectal cancer-a case report and literature review

    Author: Deng, Ya-Ya; Chen, Yun-Wang; Wang, Ming -Xing; Zhu, Peng-Fei; Pan, Shuan-Yue; Jiang, Ding-Yi; Chen, Zhe-Ling; Yang, Liu

    Journal: TRANSLATIONAL CANCER RESEARCH. 2023; Vol. 12, Issue 1, pp. 177-+. DOI: 10.21037/tcr-22-1872